Pholcodine: Difference between revisions
Brian Blank (talk | contribs) No edit summary |
m Protected "Pholcodine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
(No difference)
|
Revision as of 19:28, 27 September 2011
Clinical data | |
---|---|
Pregnancy category |
|
Dependence liability | Low |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | ? |
Metabolism | Hepatic |
Elimination half-life | ? |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C23H30N2O4 |
Molar mass | 398.55 g/mol |
WikiDoc Resources for Pholcodine |
Articles |
---|
Most recent articles on Pholcodine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Pholcodine at Clinical Trials.gov Clinical Trials on Pholcodine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Pholcodine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Pholcodine Discussion groups on Pholcodine Patient Handouts on Pholcodine Directions to Hospitals Treating Pholcodine Risk calculators and risk factors for Pholcodine
|
Healthcare Provider Resources |
Causes & Risk Factors for Pholcodine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Pholcodine is a modified opiate cough suppressant (antitussive) that acts primarily on the central nervous system (CNS) causing depression of the cough reflex, partly by a direct effect on the cough centre in the medulla. It also has a mild sedative effect, yet has little or no analgesic action. It is readily absorbed from the gastrointestinal tract and freely crosses the blood-brain barrier. It is metabolized in the liver and its action may be prolonged in hepatic insufficiency. Pholcodine is found in cough lozenges. It helps suppress unproductive coughs and acts an antifungal agent.
Side effects
Side effects are rare and may include dizziness and gastrointestinal disturbances such as nausea or vomiting.
Adverse effects such as constipation, drowsiness, excitation, ataxia and respiratory depression have been reported occasionally or after large doses.
See also
- Other cough suppressants
External links
- Australian Therapeutic Goods Admission document on Pholcodine (Rich Text Format)
- Pages with script errors
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Antitussives